Clinical trial

ABA-101 in Participants With Progressive Multiple Sclerosis

NCT06566261

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2024-09-11

PhasePHASE1

Study timeline

Study start (actual)2024-09-11Date precision: day

Registry last updated2025-07-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Progressive Multiple Sclerosisunresolved

Interventions

ABA-101BIOLOGICAL

Sponsors & collaborators

Abata Therapeuticslead sponsor

Mapped research locations

BaltimoreMaryland, United States1 ClevelandOhio, United States1 New BrunswickNew Jersey, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06566261 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.